300 reports

  • DRIVERS OF DEGREE OF RIVALRY IN THE PHARMACEUTICALS MARKET IN AUSTRALIA, 2016
  • AUSTRALIA PHARMACEUTICALS MARKET VALUE: $ BILLION, 2012-16

Pharmaceuticals in Australia Summary Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics...

  • Pharmaceutical
  • Australia
  • Oceania
  • Aspen Pharmacare Holdings Limited
  • AstraZeneca PLC
  • Federal funding for the Pharmaceutical Benefits Scheme
  • Products and services segmentation (2017-18)

Sugar pills: Firms have pursued non-PBS revenue streams to support revenue growth Abstract Pharmaceuticals Wholesaling in Australia The industry is made up of companies that wholesale pharmaceutical products, including prescription drugs, over-the-counter medicines and complementary...

  • Pharmaceutical
  • Pharmacy
  • Australia
  • Demand
  • Federal funding for the pharmaceutical benefits scheme
  • Industry at a Glance

Bitter pill: Reform-driven pricing pressures have caused industry revenue to decline Abstract Pharmaceutical Product Manufacturing in Australia The industry comprises companies that manufacture medicinal and pharmaceutical products for human use from both synthetic (chemical) and natural...

  • Pharmaceutical
  • Australia
  • Demand
  • Trade
  • Distribution of enterprises vs. population
  • Capital intensity

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Pharmaceutical
  • Veterinary Healthcare
  • Australia
  • Demand
  • Virbac SA
  • Australian Chemical and Pharmaceutical Plants Construction, Repair & Maintenance
  • Australian Chemical and Pharmaceutical Plants Construction, Refurbishment Output

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in Australia to 2020: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical plants construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance,...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • Australian Chemical and Pharmaceutical Plants construction Output, Refurbishment by
  • Australian Chemical and Pharmaceutical Plants construction Output, Refurbishment by

Synopsis Timetric’s "Chemical and Pharmaceutical Plants (Construction) in Australia: Market Analytics by Category & Cost Type to 2022" contains historic and forecast market data for the chemical and pharmaceutical plants category in Australia, it also provides detailed breakdown of the data by construction activity (new...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • Capital intensity
  • About this Industry

High capital intensity is more than $##. ## of capital to $## of labour; medium is $##. ## to $##. ## of capital to $## of labour; low is less than $##. ## of capital for every $## of labour.

  • Non-Store Retail
  • Pharmaceutical
  • Pharmacy
  • Australia
  • Demand
  • Pharmaceuticals Packing and Labelling Services in Australia
  • Major market segmentation (2017-18)

Packing it in: The offshoring of upstream manufacturing capability is constraining demand Abstract Pharmaceuticals Packing and Labelling Services in AustraliaIndustry operators provide packaging and labelling services to manufacturers and wholesalers of pharmaceutical goods on contract.This report...

  • Pharmaceutical
  • Australia
  • Demand
  • Forecast
  • Amcor Limited
  • 4.2 Pharmaceutical & Healthcare Online Ad Spend
  • Australia Pharmaceutical & Healthcare Brands' Online Advertising Spend - Breakdown by Marketing Objective (%), 2015 vs. 2020

Online advertising spend by pharmaceutical & healthcare brands in Australia stood at US$170 million by end of 2015, accounting for 3.2% of total online advertising. During 2011-2015, online advertising in this industry has increased at a CAGR of 18.8%. This growth is expected to continue in 2016 with brands expected to spend US$198 million,...

  • Online Advertising
  • Pharmaceutical
  • Social Network
  • Australia
  • Forecast
  • 5.2 Pharmaceutical & Healthcare Social Media Ad Spend
  • Australia Pharmaceutical & Healthcare Brands' Advertising Spend on Social Media - Breakdown by Marketing Objective (%), 2015 vs. 2020

Social media advertising spend by pharmaceutical & healthcare brands in Australia stood at US$27 million by end of 2015, accounting for 2.7% of total social media advertising. During 2011-2015, social media advertising in this industry has increased at a CAGR of 32.1%. This growth is expected to continue in 2016 with brands expected to spend...

  • Advertising
  • Pharmaceutical
  • Social Network
  • Australia
  • Forecast
  • PRICE BUILD UP
  • PRICING

However, the Pharmaceutical Benefits Pricing Authority (PBPA) was disbanded on ## April 2014 (see ' Disbanding of the PBPA', above).

  • Health Services
  • Healthcare
  • Hospital
  • Pharmaceutical
  • Australia

Australian Pharmaceutical Industries Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report ## Table of Contents ##. ## List of Tables ##. ## List of Figures ## Introduction to the Company ##. ## Australian Pharmaceutical Industries Limited- Key

  • Pharmaceutical
  • Australasia
  • Australia
  • Market Size
  • KEY PHARMACEUTICALS PTY LTD

Key Pharmaceuticals’ strategy involves growing its share through the offer of safe, effective and high-quality products. The company prides itself on being Australian-owned and operated. It owns the majority of its brands, while some are also manufactured under exclusive licensing and distribution agreements. Euromonitor International...

  • OTC
  • Pharmaceutical
  • Weight Loss
  • Australia
  • Demand

OVERVIEW IT OPERATES IN ## BUSINESS DIVISIONS ##) CONSUMER ##) PHARMACEUTICAL ##. ##. ##.

  • Pharmaceutical
  • Australia
  • Market Size
  • Gilead Sciences, Inc.
  • Pfizer Inc.
  • 3.1.2 Pharmaceutical Exports and Imports
  • 4.2.8 Pharmaceutical Advertising Regulations

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia”. The report is an essential source of information on and analysis of the healthcare,...

  • Pharmaceutical
  • Australia
  • Market Size
  • AstraZeneca PLC
  • Pfizer Inc.
  • Bargaining Power of Suppliers in the Australian Generics Industry
  • Bargaining Power of Suppliers

The company is one the world' s largest active pharmaceutical ingredients (APIs) producers.

  • Pharmaceutical
  • APAC
  • Australia
  • United States
  • World
  • Teva Pharmaceutical Industries Limited: key financials ($)
  • Teva Pharmaceutical Industries Limited: key financial ratios

Generics in Australia Summary Generics in Australia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics...

  • Pharmaceutical
  • Australia
  • Aspen Pharmacare Holdings Limited
  • Mylan Inc.
  • Teva Pharmaceutical Industries Ltd.

OVERVIEW P A G E | ## ## ## IT OPERATES IN ## BUSINESS DIVISIONS ##) CONSUMER ##) PHARMACEUTICAL ##. ##. ##.

  • Pharmaceutical
  • Australia
  • Market Size
  • Gilead Sciences, Inc.
  • Pfizer Inc.

Sigma Pharmaceuticals Ltd.

  • Pharmaceutical
  • Australasia
  • Australia
  • Market Competition
  • 4.2 Chemical and Pharmaceutical Plants construction Output Value
  • 4.1 Chemical and Pharmaceutical Plants construction Output Value,

Synopsis Timetric’s "Industrial Construction Market in Australia: Market Size, Growth and Forecast Analytics to 2022" contains historic and forecast market data for the industrial construction market in Australia, with a detailed breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment...

  • Construction
  • Pharmaceutical
  • Australia
  • Market Size
  • Supply
  • 27.4 LEGAL AND REGULATORY

BETWEEN 1994 AND 2005, PATERSON SERVED AT ROCHE PHARMACEUTICALS.

  • Pharmaceutical
  • Australia
  • Forecast
  • Medtronic, Inc.
  • Olympus Corporation
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Average Construction Value (AUD / Square Feet), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 7.5% to reach US$ 293.4 billion by 2022. The industrial building construction market in value terms is expected to reach US$ 4.5 billion in 2018. This report from ConsTrack360 provides data-centric analyses on industrial construction...

  • Industrial Construction
  • Pharmaceutical
  • Australia
  • Forecast
  • Market Size
  • AUSTRALIAN PHARMACEUTICAL INDUSTRIES LTD
  • Australian Pharmaceutical Industries: Private Label Portfolio

Australian Pharmaceutical Industries (API) remains focused on growing its Priceline network of stores and the expansion of its health and beauty retail brand portfolio. The company re-signed Australian of the Year, Ita Buttrose as a Priceline Ambassador in 2013 to help strengthen its health credentials. Furthermore, API will look to grow its...

  • Pharmaceutical
  • Australia
  • Market Size
  • Australian Pharmaceutical Industries Limited
  • Priceline Group
  • COPD: KEY METRICS IN THE EIGHT MAJOR PHARMACEUTICAL MARKETS
  • Strengths

PharmaPoint: Chronic Obstructive Pulmonary Disease - Global Drug Forecast and Market Analysis to 2025 Summary COPD is a progressive lung disease characterized by an abnormal inflammatory response and airflow obstruction that is not fully reversible. Chronic airflow limitation is caused by both small airway diseases,...

  • Pharmaceutical
  • Australia
  • North America
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Pharma and biotech
  • Pharmaceutical sales

Disease trends;Healthcare;Healthcare;Pharmaceuticals and biotechnology;Healthcare;Provision;Healthcare;Spending NCAIS: 62 SIC: 80

  • Healthcare
  • Pharmaceutical
  • Australia
  • Demand
  • Social Conditions
  • ELI LILLY'S RA PORTFOLIO ASSESSMENT, 2016
  • BMS' RA PORTFOLIO ASSESSMENT, 2016

FIRSTWORD PHARMA.

  • Pharmaceutical
  • Australia
  • AbbVie Inc.
  • Pfizer Inc.
  • Remicade group
  • Pharma and biotech
  • Pharmaceutical sales

Healthcare expenditure in Australia accounted for 9.4% of GDP in 2014, according to the World Health Organisation (WHO). The Economist Intelligence Unit estimates that this rose to 9.6% in 2016, and will rise further to 9.7% in 2021. According to the WHO, 67% of Australia's healthcare spending in 2014 came from general...

  • Healthcare
  • Pharmaceutical
  • Australia
  • Demand
  • Forecast
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (AUD Million), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022

Report Description The non residential construction industry in value terms increased at a CAGR of 7.0% during 2013-2017. The commercial building construction market in value terms is expected to record a CAGR of 6.2% over the forecast period. The industrial building construction market in value terms is expected to reach...

  • Commercial Construction
  • Pharmaceutical
  • Australia
  • Forecast
  • Market Size
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (AUD Million), 2013 - 2022
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Value (AUD Million), 2013 - 2022

Report Description During the review period, value of building construction industry recorded a CAGR of 9.8%. CAGR during the forecast period of 2018 to 2022 is expected to be 8.9%. The residential construction industry in value terms increased at a CAGR of 11.4% during 2013-2017. The commercial building construction market...

  • Commercial Construction
  • Pharmaceutical
  • Australia
  • Forecast
  • Market Size
  • Chemical & Pharmaceutical Building Construction - Market Size & Forecast by Volume (Million Square Feet), 2013 - 2022
  • Chemical & Pharmaceutical Building Average Construction Value (AUD / Square Feet), 2013 - 2022

Report Description The construction industry in value terms is expected to record a CAGR of 7.5% to reach US$ 293.4 billion by 2022. The residential construction industry in value terms increased at a CAGR of 11.4% during 2013-2017. The commercial building construction market in value terms is expected to record a CAGR...

  • Construction
  • Pharmaceutical
  • Australia
  • Forecast
  • Market Size